RIBOGENE

RiboGene is a drug discovery company focused on the identification of novel leads and the development of potential drug candidates for the treatment of infectious diseases. The Company's drug discovery efforts target bacterial, fungal and viral infections for which the efficacy of existing therapies is being threatened by the emergence of drug resistance or for which existing therapies have had limited effectiveness. The Company's drug discovery technology is based on the translational control of gene expression.

#SimilarOrganizations #Financial #More

RIBOGENE

Industry:
Biotechnology Genetics Health Care

Founded:
1989-01-01

Address:
Hayward, California, United States

Country:
United States

Total Employee:
11+

Status:
Active


Similar Organizations

bikam-pharmaceuticals-logo

BIKAM Pharmaceuticals

BIKAM Pharmaceuticals is a drug discovery company focused on the discovery and development of novel drugs for degenerative diseases.

zymenex-logo

Zymenex

Zymenex is a Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies

Stock Details


Company's stock symbol is NYSEMKT:RBO

Acquisitions List

Date Company Article Price
1994-01-01 Darby Pharmaceuticals Darby Pharmaceuticals acquired by RiboGene 4.4 M USD

More informations about "RiboGene" on Search Engine